Cargando…

Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic

Detalles Bibliográficos
Autores principales:	Hosangadi, Divya, Warmbrod, Kelsey Lane, Martin, Elena K., Adalja, Amesh, Cicero, Anita, Inglesby, Thomas, Watson, Crystal, Watson, Matthew, Connell, Nancy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167542/ https://www.ncbi.nlm.nih.gov/pubmed/32381478 http://dx.doi.org/10.1016/j.vaccine.2020.04.037

Ejemplares similares

Characteristics of Microbes Most Likely to Cause Pandemics and Global Catastrophes
por: Adalja, Amesh A., et al.
Publicado: (2019)

Building the global vaccine manufacturing capacity needed to respond to pandemics
por: Sell, Tara Kirk, et al.
Publicado: (2021)

Global Catastrophic Biological Risks: Toward a Working Definition
por: Schoch-Spana, Monica, et al.
Publicado: (2017)

Innovative approaches to COVID-19 medical countermeasure development
por: Harris, Gavin H, et al.
Publicado: (2023)

Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future
por: Hosangadi, Divya, et al.
Publicado: (2021)

Biothreat Agents and Emerging Infectious Disease in the Emergency Department
por: Adalja, Amesh A.
Publicado: (2018)

The words that shaped COVID-19
por: Adalja, Amesh
Publicado: (2021)

Anthrax: has the clinical milieu changed since 2001?
por: Adalja, Amesh A.
Publicado: (2012)

Deadliest Enemy: Our War against Killer Germs
por: Adalja, Amesh A.
Publicado: (2018)

At-home infectious disease testing: An idea whose time has come
por: Adalja, Amesh A.
Publicado: (2022)

Lessons Learned during Dengue Outbreaks in the United States, 2001–2011
por: Adalja, Amesh A., et al.
Publicado: (2012)

Genetically Modified (GM) Mosquito Use to Reduce Mosquito-Transmitted Disease in the US: A Community Opinion Survey
por: Adalja, Amesh, et al.
Publicado: (2016)

Patents as a Driver of the Unprecedented Biomedical Response to COVID-19
por: Mossoff, Adam, et al.
Publicado: (2022)

Strengthening the US Medical Countermeasure Enterprise for Biological Threats
por: Ravi, Sanjana, et al.
Publicado: (2017)

Clostridium difficile: moving beyond antimicrobial therapy
por: Adalja, Amesh A, et al.
Publicado: (2010)

Original Antigenic Sin and Pandemic (H1N1) 2009
por: Adalja, Amesh A., et al.
Publicado: (2010)

Using prediction polling to harness collective intelligence for disease forecasting
por: Sell, Tara Kirk, et al.
Publicado: (2021)

Protecting the Nation from Health Security Threats
por: Inglesby, Tom, et al.
Publicado: (2017)

COVID‐19 and the gain of function debates: Improving biosafety measures requires a more precise definition of which experiments would raise safety concerns
por: Warmbrod, Kelsey Lane, et al.
Publicado: (2021)

Digital Innovation Enabled Nanomaterial Manufacturing; Machine Learning Strategies and Green Perspectives
por: Konstantopoulos, Georgios, et al.
Publicado: (2022)

Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020)

Misinformation and the US Ebola communication crisis: analyzing the veracity and content of social media messages related to a fear-inducing infectious disease outbreak
por: Sell, Tara Kirk, et al.
Publicado: (2020)

Additive manufacturing-enabled design, manufacturing, and lifecycle performance
por: Peng, Tao, et al.
Publicado: (2020)

The Promise of Disease Detection Dogs in Pandemic Response: Lessons Learned From COVID-19
por: Otto, Cynthia M., et al.
Publicado: (2021)

A Modular-Incremental Approach to Improving Compliance Verification With the Biological Weapons Convention
por: Cropper, Nicholas R., et al.
Publicado: (2023)

The Joint External Evaluation of Taiwan: The External Evaluators' Perspective
por: Toner, Eric S., et al.
Publicado: (2017)

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)

Improving Understanding of and Response to Infodemics During Public Health Emergencies
por: Sell, Tara Kirk, et al.
Publicado: (2021)

Isolation of Aspergillus in three 2009 H1N1 influenza patients
por: Adalja, Amesh A., et al.
Publicado: (2011)

CVD-Enabled Graphene Manufacture and Technology
por: Hofmann, Stephan, et al.
Publicado: (2015)

Additive manufacturing: innovations, advances, and applications
por: Srivatsan, T S, et al.
Publicado: (2015)

Recent Advances in Manufacturing Innovative Stents
por: Beshchasna, Natalia, et al.
Publicado: (2020)

Services Innovation: Decision Attributes, Innovation Enablers, and Innovation Drivers
por: Tien, James M.
Publicado: (2007)

Additive Manufacturing: Alloy Design and Process Innovations
por: Prashanth, Konda Gokuldoss, et al.
Publicado: (2020)

Will Innovation of Pharmaceutical Manufacturing Improve Perceived Health?
por: Li, Zejun, et al.
Publicado: (2021)

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin
por: Kargbo, Robert B., et al.
Publicado: (2020)

Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter
por: Buehrle, Deanna J., et al.
Publicado: (2020)

Innovative Concepts in Inflammatory Bowel Diseases
por: Watson, Peter
Publicado: (1999)

Automated Computer Vision-Enabled Manufacturing of Nanowire Devices
por: Potočnik, Teja, et al.
Publicado: (2022)

Dynamic metastable polymersomes enable continuous flow manufacturing
por: Wong, Chin Ken, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nq614cnn3kqefob9h38in3iiej